X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4804) 4804
Book Chapter (90) 90
Newsletter (37) 37
Magazine Article (13) 13
Dissertation (6) 6
Book / eBook (5) 5
Publication (3) 3
Conference Proceeding (2) 2
Newspaper Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4341) 4341
burkitt lymphoma - pathology (3043) 3043
science & technology (2564) 2564
life sciences & biomedicine (2469) 2469
male (1851) 1851
female (1499) 1499
child (1182) 1182
adult (991) 991
oncology (955) 955
adolescent (902) 902
burkitt lymphoma - genetics (900) 900
burkitt's lymphoma (833) 833
hematology (833) 833
child, preschool (804) 804
burkitt lymphoma - drug therapy (703) 703
burkitt lymphoma (692) 692
abridged index medicus (683) 683
animals (680) 680
middle aged (676) 676
lymphomas (616) 616
burkitt lymphoma - diagnosis (607) 607
burkitt lymphoma - immunology (563) 563
tumor cells, cultured (541) 541
burkitt lymphoma - metabolism (483) 483
pathology (455) 455
aged (444) 444
mice (443) 443
lymphoma (425) 425
hemic and lymphatic diseases (383) 383
cell line, tumor (369) 369
cancer (358) 358
diagnosis, differential (356) 356
antineoplastic combined chemotherapy protocols - therapeutic use (351) 351
apoptosis (348) 348
cell line (343) 343
burkitt lymphoma - complications (319) 319
prognosis (317) 317
translocation, genetic (293) 293
infant (283) 283
lymphoma - pathology (279) 279
burkitt lymphoma - virology (278) 278
burkitt lymphoma - epidemiology (276) 276
b-lymphocytes - pathology (255) 255
burkitt lymphoma - therapy (255) 255
immunology (254) 254
pediatrics (254) 254
cell biology (247) 247
epstein-barr virus (243) 243
herpesvirus 4, human - genetics (237) 237
lymphoma, large b-cell, diffuse - pathology (237) 237
apoptosis - drug effects (236) 236
flow cytometry (233) 233
immunohistochemistry (232) 232
bone marrow - pathology (231) 231
biopsy (227) 227
immunophenotyping (227) 227
research (222) 222
lymphoma, non-hodgkin - pathology (219) 219
chemotherapy (212) 212
treatment outcome (206) 206
retrospective studies (202) 202
gene expression (195) 195
lymphoma, b-cell - pathology (195) 195
molecular sequence data (195) 195
neoplasm staging (194) 194
biochemistry & molecular biology (189) 189
base sequence (188) 188
tumors (185) 185
diagnosis (184) 184
leukemia (184) 184
b-lymphocytes - immunology (183) 183
burkitt lymphoma - etiology (175) 175
immune system diseases (174) 174
research article (173) 173
herpesvirus 4, human - isolation & purification (171) 171
herpesvirus 4, human - immunology (167) 167
gene expression regulation, neoplastic (166) 166
health aspects (165) 165
precursor cell lymphoblastic leukemia-lymphoma - pathology (163) 163
polymerase chain reaction (162) 162
genetic aspects (161) 161
analysis (157) 157
aids/hiv (154) 154
b-lymphocytes - metabolism (150) 150
tomography, x-ray computed (149) 149
lymph nodes - pathology (148) 148
burkitt lymphoma - mortality (145) 145
lymphocytes b (144) 144
karyotyping (143) 143
care and treatment (141) 141
aged, 80 and over (140) 140
burkitt lymphoma - diagnostic imaging (134) 134
children (134) 134
proteins (134) 134
cells, cultured (130) 130
herpesvirus 4, human (129) 129
in situ hybridization, fluorescence (129) 129
time factors (128) 128
genes, myc (127) 127
burkitt lymphoma - microbiology (126) 126
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4575) 4575
French (113) 113
Chinese (85) 85
German (78) 78
Japanese (63) 63
Spanish (60) 60
Russian (29) 29
Italian (21) 21
Polish (17) 17
Hungarian (10) 10
Danish (6) 6
Dutch (4) 4
Portuguese (4) 4
Croatian (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Czech (2) 2
Hebrew (2) 2
Romanian (2) 2
Finnish (1) 1
Korean (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of molecular sciences, ISSN 1422-0067, 08/2018, Volume 19, Issue 9, p. 2475
With the introduction of next generation sequencing methods, such as RNA sequencing, it has become apparent that alterations in the non-coding regions of our... 
B-cell development | Burkitt lymphoma (BL) | Mantle cell lymphoma (MCL) | Gene regulation | Diffuse large b-cell lymphoma (DLBCL) | Circular RNA | Chronic lymphocytic leukemia (CLL) | Acute lymphoblastic leukemia (ALL) | Long non-coding RNA | Multiple myeloma (MM) | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology | Humans | Gene Expression Regulation, Neoplastic | Lymphoma, Mantle-Cell - pathology | Multiple Myeloma - immunology | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA - genetics | Burkitt Lymphoma - pathology | RNA, Long Noncoding - immunology | Lymphoma, Follicular - genetics | Burkitt Lymphoma - immunology | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Large B-Cell, Diffuse - immunology | Cell Differentiation | B-Lymphocytes - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Lymphoma, Mantle-Cell - genetics | Lymphoma, Large B-Cell, Diffuse - pathology | RNA - immunology | Signal Transduction | Lymphoma, Follicular - pathology | RNA, Long Noncoding - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Cell Transformation, Neoplastic - immunology | Multiple Myeloma - pathology | B-Lymphocytes - immunology | Lymphoma, Follicular - immunology | Lymphoma, Mantle-Cell - immunology | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Multiple Myeloma - genetics | Transformation | Deregulation | Leukemia | Differentiation (biology) | Multiple myeloma | Effector cells | Genomes | Malignancy | Gene sequencing | Peripheral blood | Bone marrow | Clonal selection | Chronic lymphatic leukemia | Acute lymphatic leukemia | V(D)J recombination | Lymphatic leukemia | Gene expression | Ribonucleic acid--RNA | Burkitt's lymphoma | Somatic hypermutation | Blood circulation | Lymphocytes B | Mantle cell lymphoma | Lymphomas | Cancer | B-cell lymphoma | Genomics | Metastasis | Kinases | Proteins | Next-generation sequencing | Transfer RNA | Enzymes | Cyclin-dependent kinases | Acids | Protein synthesis | MicroRNAs | Binding sites | Index Medicus | diffuse large B-cell lymphoma (DLBCL) | chronic lymphocytic leukemia (CLL) | burkitt lymphoma (BL) | gene regulation | circular RNA | acute lymphoblastic leukemia (ALL) | long non-coding RNA | mantle cell lymphoma (MCL) | multiple myeloma (MM)
Journal Article
American journal of hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 790 - 795
Journal Article
Clinical cancer research, ISSN 1557-3265, 08/2017, Volume 23, Issue 15, pp. 4212 - 4223
Purpose: Patients with B-cell lymphomas often relapse after frontline therapy, and novel therapies are urgently needed to provide long-term remission... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Lymphoma, Follicular - drug therapy | Humans | Lymphoma, Mantle-Cell - pathology | Protein Kinase Inhibitors - adverse effects | Burkitt Lymphoma - pathology | Protein-Tyrosine Kinases - genetics | Lymphoma, Follicular - genetics | Burkitt Lymphoma - genetics | Lymphoma, B-Cell, Marginal Zone - pathology | Gene Expression Regulation, Neoplastic - drug effects | Lymphoma, Mantle-Cell - genetics | Burkitt Lymphoma - drug therapy | Disease Models, Animal | Precision Medicine | Pyrazoles - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Follicular - pathology | Pyrimidines - administration & dosage | Lymphoma, Mantle-Cell - drug therapy | Drug Discovery | Lymphoma, B-Cell, Marginal Zone - genetics | Phosphatidylinositol 3-Kinases - genetics | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Pyrazoles - administration & dosage | Animals | Signal Transduction - drug effects | Lymphoma, B-Cell, Marginal Zone - drug therapy | Lymphoma, Large B-Cell, Diffuse - classification | Pyrimidines - adverse effects | Mice | Lymphoma, Large B-Cell, Diffuse - genetics | Cell culture | Therapy | Animal models | Kinases | Inactivation | Signal transduction | Biological effects | Peripheral blood | Xenografts | Remission | Protein-tyrosine kinase | Tyrosine | Deactivation | Tumor cells | Patients | Lymphoma | 1-Phosphatidylinositol 3-kinase | Burkitt's lymphoma | Signaling | Inhibitors | Lymphocytes B | Experimental design | Mantle cell lymphoma | Lymphomas | Mutation | Tumors | Cancer | B-cell lymphoma | Index Medicus | patient-derived xenograft | personalized therapy
Journal Article
Primary care, ISSN 0095-4543, 12/2016, Volume 43, Issue 4, pp. 661 - 675
Lymphomas may be broadly divided into non-Hodgkin (90%) and Hodgkin (10%) types. Most lymphomas (90%) are of B cell origin but can also be T cell or natural killer cell... 
Diffuse large B cell | T cell | Burkitt | Non-Hodgkin | Hodgkin | Follicular | Lymphoma | MALT | Medicine, General & Internal | Primary Health Care | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Decision Making | Lymphoma - therapy | Humans | Quality of Life | Lymphoma - pathology | Antineoplastic Agents - therapeutic use | Disease Management | Index Medicus
Journal Article
Journal Article
Cancer science, ISSN 1347-9032, 07/2014, Volume 105, Issue 7, pp. 897 - 904
Journal Article
Journal Article